Merck (MRK) Enterprise Value (2009 - 2026)
Merck (MRK) reported Enterprise Value of -$5.6 billion for Q1 2026, up 38.35% year-over-year from -$4.1 billion in Q1 2025, and up 61.07% on a QoQ basis from -$14.5 billion in Q4 2025.
Merck (MRK) has 18 years of Enterprise Value data on file, last reported at -$5.6 billion in Q1 2026.
- Quarterly Enterprise Value rose 38.35% year-over-year to -$5.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.6 billion (up 38.35% YoY) and the FY2025 annual result came in at -$14.5 billion, down 6.45% from the prior year.
- Enterprise Value rose to -$5.6 billion in Q1 2026 per MRK's latest filing, from -$14.5 billion in the prior quarter.
- Across five years, Enterprise Value topped out at -$5.6 billion in Q1 2024 and bottomed at -$18.2 billion in Q3 2025.
- The 5-year median for Enterprise Value is -$10.1 billion (2022), against an average of -$10.4 billion.
- The widest annual swing landed in 2023, when Enterprise Value surged 46.37%; it then plunged 93.64% in 2024.
- Tracing MRK's Enterprise Value over 5 years: stood at -$13.1 billion in 2022, then jumped by 46.37% to -$7.0 billion in 2023, then sank by 93.64% to -$13.6 billion in 2024, then dropped by 6.45% to -$14.5 billion in 2025, then jumped by 61.07% to -$5.6 billion in 2026.
- Per Business Quant, the three latest MRK Enterprise Value figures stand at -$5.6 billion (Q1 2026), -$14.5 billion (Q4 2025), and -$18.2 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -5.28 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | -22.05 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -9.35 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -5.65 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | -12.04 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | -7.73 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -12.77 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -10.45 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | -4.68 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.65 Bn |
| Dec 31, 2025 | -14.51 Bn |
| Sep 30, 2025 | -18.16 Bn |
| Jun 30, 2025 | -8.56 Bn |
| Mar 31, 2025 | -9.16 Bn |
| Dec 31, 2024 | -13.63 Bn |
| Sep 30, 2024 | -14.54 Bn |
| Jun 30, 2024 | -11.29 Bn |
| Mar 31, 2024 | -5.56 Bn |
| Dec 31, 2023 | -7.04 Bn |
| Sep 30, 2023 | -8.72 Bn |
| Jun 30, 2023 | -6.33 Bn |
| Mar 31, 2023 | -10.32 Bn |
| Dec 31, 2022 | -13.13 Bn |
| Sep 30, 2022 | -11.18 Bn |
| Jun 30, 2022 | -10.05 Bn |
| Mar 31, 2022 | -8.86 Bn |
| Dec 31, 2021 | -8.02 Bn |
| Sep 30, 2021 | -9.95 Bn |
| Jun 30, 2021 | -8.48 Bn |
| Mar 31, 2021 | -6.89 Bn |
| Dec 31, 2020 | -7.96 Bn |
| Sep 30, 2020 | -7.27 Bn |
| Jun 30, 2020 | -11.00 Bn |
| Mar 31, 2020 | -7.34 Bn |
| Dec 31, 2019 | -10.36 Bn |
| Sep 30, 2019 | -7.93 Bn |
| Jun 30, 2019 | -7.00 Bn |
| Mar 31, 2019 | -8.67 Bn |
| Dec 31, 2018 | -8.68 Bn |
| Sep 30, 2018 | -10.05 Bn |
| Jun 30, 2018 | -7.36 Bn |
| Mar 31, 2018 | -7.11 Bn |
| Dec 31, 2017 | -8.27 Bn |
| Sep 30, 2017 | -16.05 Bn |
| Jun 30, 2017 | -13.82 Bn |
| Mar 31, 2017 | -14.39 Bn |
| Dec 31, 2016 | -14.12 Bn |
| Sep 30, 2016 | -12.85 Bn |
| Jun 30, 2016 | -11.75 Bn |
| Mar 31, 2016 | -12.85 Bn |
| Dec 31, 2015 | -13.34 Bn |
| Sep 30, 2015 | -12.00 Bn |
| Jun 30, 2015 | -11.18 Bn |
| Mar 31, 2015 | -15.45 Bn |
| Dec 31, 2014 | -15.58 Bn |
| Sep 30, 2014 | -14.21 Bn |
| Jun 30, 2014 | -13.24 Bn |
| Mar 31, 2014 | -17.92 Bn |
| Dec 31, 2013 | -14.93 Bn |
| Sep 30, 2013 | -15.58 Bn |
| Jun 30, 2013 | -15.49 Bn |
| Mar 31, 2013 | -13.02 Bn |
| Dec 31, 2012 | -13.70 Bn |
| Sep 30, 2012 | -17.36 Bn |
| Jun 30, 2012 | -14.97 Bn |
| Mar 31, 2012 | -13.11 Bn |
| Dec 31, 2011 | -12.55 Bn |
| Sep 30, 2011 | -12.17 Bn |
| Jun 30, 2011 | -11.56 Bn |
| Mar 31, 2011 | -10.57 Bn |
| Dec 31, 2010 | -9.77 Bn |
| Sep 30, 2010 | -8.17 Bn |
| Jun 30, 2010 | -7.51 Bn |
| Mar 31, 2010 | -7.31 Bn |
| Dec 31, 2009 | -7.18 Bn |
| Sep 30, 2009 | -22.30 Bn |
| Jun 30, 2009 | -13.87 Bn |
| Mar 31, 2009 | -6.02 Bn |